Showing results (1071-1080 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1996
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitorR T Dorr, K Dvorakova, K Snead, et al.Investigational New Drugs|January 1, 1996
Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitroI Djuanda, H Depenbrock, R Peter, et al.Investigational New Drugs|January 1, 1996
Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agentsM J Kelner, T C McMorris, L Estes, et al.Investigational New Drugs|January 1, 1996
In vitro cytotoxicity of S16020-2, a new olivacine derivativeS Léonce, V Perez, M R Casabianca-Pignede, et al.Investigational New Drugs|January 1, 1996
Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials GroupP Forsyth, G Cairncross, D Stewart, et al.Investigational New Drugs|January 1, 1996
A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinomaK D Miller, P J Loehrer, R Gonin, et al.Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.Investigational New Drugs|January 1, 1996
Phase I trials in paediatric oncology--the European perspective. The New Agents Group of the United Kingdom Childrens Cancer Study GroupE J Estlin, S Ablett, D R Newell, et al.Investigational New Drugs|January 1, 1996
Preclinical antitumor activity of CI-994P M LoRusso, L Demchik, B Foster, et al.Pageof 372